Dual incretin agonist: difference between revisions
Diff·revision 19 → 20·10:27, 13 May 2025
Difference between revision 19 and revision 20 of Dual incretin agonist. 1 line changed; the page grew by 18 bytes.
| Revision 19 — 09:31, 21 Apr 2025 CuriousCallum (talk) the lead claimed weekly dosing for a compound dosed daily; corrected 4,734 bytes ±0 | Revision 20 — 10:27, 13 May 2025 LiraLotte (talk) expand §Design problem 4,752 bytes +18 | ||
|---|---|---|---|
| 44 | * [[Glucose-dependent insulinotropic polypeptide]] | 44 | * [[Glucose-dependent insulinotropic polypeptide]] |
| 45 | * [[CagriSema]] | 45 | * [[CagriSema]] |
| + | 46 | * [[Survodutide]] | |
| 46 | 47 | ||
| 47 | {{DEFAULTSORT:Dual incretin agonist}} | 48 | {{DEFAULTSORT:Dual incretin agonist}} |